feed,title,long_url,short_url
MedRxiv,"Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study",https://medrxiv.org/cgi/content/short/2021.10.04.21264483v1?rss=1,https://j.mp/2YkAMUM
MedRxiv,Circulating proteins to predict adverse COVID-19 outcomes,https://medrxiv.org/cgi/content/short/2021.10.04.21264015v1?rss=1,https://j.mp/3FjaZ0e
MedRxiv,Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity,https://medrxiv.org/cgi/content/short/2021.10.04.21264513v1?rss=1,https://j.mp/3uKz0c0
MedRxiv,"A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity",https://medrxiv.org/cgi/content/short/2021.10.04.21264522v1?rss=1,https://j.mp/3DdIpMa
MedRxiv,COVID-19 aerosol transmission simulation-based risk analysis for in-person learning,https://medrxiv.org/cgi/content/short/2021.10.04.21263860v1?rss=1,https://j.mp/3modWEo
